Kenneth Krogulski - Sep 5, 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Sep 5, 2023
Transactions value $
$4,704
Form type
4
Date filed
9/19/2023, 09:24 AM
Previous filing
Sep 8, 2023
Next filing
Oct 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $556 +325 +0.15% $1.71 214K Sep 5, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $546 +325 +0.15% $1.68 214K Sep 6, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $556 +325 +0.15% $1.71 215K Sep 7, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $556 +325 +0.15% $1.71 215K Sep 8, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $566 +325 +0.15% $1.74 215K Sep 11, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $582 +325 +0.15% $1.79 216K Sep 12, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $605 +325 +0.15% $1.86 216K Sep 13, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $608 +325 +0.15% $1.87 216K Sep 14, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $131 +72 +0.03% $1.82 216K Sep 15, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.